Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | PLAU | P00749 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7759107 | 0.92 | KMT2A (0.54) | ALDH1A1POLBPLAUHPGDKMT2A | |
| SCHEMBL18814229 | 0.92 | RXFP1 (0.54) | ALDH1A1POLBPLAUHPGDKMT2A | |
| SCHEMBL9126461 | 0.91 | TRPV1 (0.55) | ALDH1A1POLBPLAUHPGDKMT2A | |
| SCHEMBL283066 | 0.88 | ALDH1A1 (0.71) | ALDH1A1PLAUHPGDKMT2AMEN1 | |
| SCHEMBL11659356 | 0.84 | HPGD (0.64) | ALDH1A1POLBPLAUHPGDKMT2A | |
| SCHEMBL29469890 | 0.83 | ALDH1A1 (0.44) | ALDH1A1POLBPLAUHPGDKMT2A | |
| SCHEMBL9125816 | 0.83 | IDO1 (0.59) | ALDH1A1HPGDKMT2AMEN1HTT | |
| SCHEMBL7785858 | 0.83 | HPGD (0.57) | ALDH1A1POLBPLAUHPGDKMT2A | |
| SCHEMBL7256914 | 0.83 | HPGD (0.52) | ALDH1A1POLBPLAUHPGDKMT2A | |
| SCHEMBL30900905 | 0.82 | PARP1 (0.61) | ALDH1A1PLAUHPGDKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4069240-A | GROUP 8 METAL CATALYST | UNIROYAL, INC. (US) | 1978-01-17 | — | — | US | claimed |
| WO-2023168889-A1 | PREPARATION METHOD FOR ALICYCLIC CARBAMATE AND USE THEREOF | 中国科学院过程工程研究所 | 2023-09-14 | — | — | WO | disclosed |
| US-8969577-B2 | Curable composition comprising a thermolatent base | BASF SE (DE) | 2015-03-03 | — | — | US | disclosed |
| US-8969577-B2 | Curable composition comprising a thermolatent base | BASF SE (DE) | 2015-03-03 | — | — | US | disclosed |
| US-20110245375-A1 | CURABLE COMPOSITION COMPRISING A THERMOLATENT BASE | BASF SE (DE) | 2011-10-06 | — | — | US | disclosed |
| US-6222065-B1 | Process for the production of 1,5-naphtylenediisocyanate | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-04-24 | — | — | US | disclosed |
| JP-2000344730-A | PRODUCTION OF 1,5-NAPHTHALENEDIISOCYANATE | MITSUBISHI GAS CHEM CO INC | 2000-12-12 | — | — | JP | disclosed |
| US-4069240-A | GROUP 8 METAL CATALYST | UNIROYAL, INC. (US) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245375-A1 | CURABLE COMPOSITION COMPRISING A THERMOLATENT BASE | COIL, MAPT, ASH2L | ALDH1A1 2185/4885POLB 966/4885PLAU 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.